Levi & Korsinsky Reminds Merck & Co., Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 – MRK

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. (“Merck” or the “Company”) (NYSE: MRK) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Merck investors who were adversely affected by alleged securities fraud between February 3, 2022 and February 3, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=134642&wire=3 

MRK investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the complaint, defendants provided investors with material information concerning Merck’s expected revenue of $11 billion from sales of Gardasil by 2030. Defendants’ statements included, among other things, confidence in Merck’s purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil’s growth in China. The full truth finally emerged on February 4, 2025, when Merck announced it would no longer achieve the long-forecasted $11 billion in sales of Gardasil by 2030, as it would cease shipments of Gardasil to China “through at least midyear” to facilitate a “rapid reduction of inventory.” Defendants claimed this was necessitated by the continued over-inflation of overall channel inventories as demand in China for Gardasil had “not recovered to the level we had expected.” Following this news, Merck’s common stock declined dramatically. From a closing market price of $99.79 per share on February 3, 2025, Merck’s stock price fell to $90.74 per share on February 4, 2025, a decline of more than 9% in the span of just a single day.

WHAT’S NEXT? If you suffered a loss in Merck during the relevant time frame, you have until April 14, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 



Arconic Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights – ARNC

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Arconic Corporation (“Arconic Corporation” or the “Company”) (NYSE: ARNC) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Arconic Corporation investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a Class of all persons who sold publicly traded shares of Arconic common stock between April 19, 2022 and May 3, 2023, both dates inclusive. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/arconic-corporation-lawsuit-submission-form?prid=134643&wire=3

ARNC investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that defendants stated in Arconic’s quarterly and annual reports issued during the Class Period that Arconic’s share repurchase programs were “intended to comply with Rule 10b5-1,” which prohibits securities trading on the basis of material nonpublic information, and that all of Arconic’s share purchases “were made in compliance with Rule 10b-18,” which provides a safe harbor for share repurchases that meet certain criteria, but does not provide a safe harbor for insider trading or other violations of the federal securities laws. However, at the time those statements were made, Arconic had made share repurchases while in possession of material nonpublic information, and therefore Arconic’s share repurchase programs were not in compliance with Rule 10b5-1, and the share repurchases were not made in compliance with Rule 10b-18. Further, defendants stated that they were continuing with share repurchases. Inasmuch as the Company was restrained by law from buying back stock during active negotiations with Apollo, the defendants’ statements with respect to ongoing stock repurchases signaled to the market that there were no, and had been no, ongoing negotiations. Accordingly, when speaking about the stock repurchases, the defendants were obligated to disclose the whole truth – that they were in, or had been in, negotiations with Apollo.

WHAT’S NEXT? If you suffered a loss in Arconic Corporation during the relevant time frame, you have until March 31, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MPWR

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Monolithic Power Systems Inc. (“Monolithic” or the “Company”) (NASDAQ: MPWR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Monolithic investors who were adversely affected by alleged securities fraud between February 8, 2024 and November 8, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=134644&wire=3 

MPWR investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a) Monolithic’s voltage regulator modules and power management integrated circuits were suffering from significant performance and quality control issues; (b) the defects listed in (a), above, had, in turn, negatively impacted the performance of certain products offered by the Company’s largest customer, Nvidia, in which such products were used; (c) Monolithic had failed to adequately address and resolve known issues affecting the performance of the power management solutions the Company supplied to Nvidia; (d) Monolithic’s relationship with Nvidia had been irreparably damaged due to the significant performance and quality control.

WHAT’S NEXT? If you suffered a loss in Monolithic during the relevant time frame, you have until April 7, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 



Upland Software to Release Fourth Quarter 2024 Financial Results on March 12, 2025

Upland Software to Release Fourth Quarter 2024 Financial Results on March 12, 2025

AUSTIN, Texas–(BUSINESS WIRE)–
Upland Software, Inc. (Nasdaq: UPLD) today announced it will release financial results for the fourth quarter 2024 before market opens on Wednesday, March 12, 2025. A conference call and webcast will follow at 11:00 a.m. Central Time /12:00 p.m. Eastern Time.

The call can be accessed via a webcast on investor.uplandsoftware.com, or by dialing 1 (800) 715-9871 toll-free (recommended for participants in North America) or 1 (646) 307-1963 (recommended for participants outside North America, standard international rates may apply). Attendees will need to use conference ID 8422976 to join the call.

Following the completion of the call, a recording of the webcast will be made available on investor.uplandsoftware.com.

About Upland Software

Upland Software Inc. enables global businesses to work smarter with over 25 proven cloud software products that increase revenue, reduce costs, and deliver immediate value. Our solutions offer many integrated AI capabilities and cover digital marketing, knowledge management, contact center service, sales productivity, content lifecycle automation, and more. Upland’s powerful cloud products are trusted by more than 10,000 global customers. Learn how Upland helps businesses achieve outcomes that matter at www.uplandsoftware.com.

Investor Relations Contact:

Mike Hill

512-960-1031

[email protected]

Media Contact:

Lloyd Berry

512-960-1010

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Software Digital Marketing Marketing Content Marketing Artificial Intelligence Communications Technology Electronic Commerce

MEDIA:

Logo
Logo

Levi & Korsinsky Reminds Novo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – NVO

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Novo investors who were adversely affected by alleged securities fraud between November 2, 2022 and December 19, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=134637&wire=3

NVO investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the complaint, on December 20, 2024, Novo issued a press release announcing the below-expected results of their “REDEFINE 1” trial, “a 68-week efficacy and safety trial investigating subcutaneous CagriSema.” The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks, well short of Novo’s targeted expectation of at least 25% weight loss. The press release further indicated that participant patients were permitted to modify their own dosage during the trial and, as a result, only 57.3% of patients treated with CagriSema were on the highest dosage contemplated by the study. Following this news, Novo’s stock price fell by $18.44 per share to close at $85.00 per share.

WHAT’S NEXT? If you suffered a loss in Novo during the relevant time frame, you have until March 25, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 



Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Crocs, Inc.(CROX) Shareholders

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Crocs investors who were adversely affected by alleged securities fraud between November 3, 2022 and October 28, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=134639&wire=3

CROX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the nature and sustainability of footwear brand, HEYDUDE’s revenue growth by concealing that 2022 revenue growth was driven, in large part, by the Company’s efforts to stock third-party wholesalers and retailers following the February 2022 acquisition of HEYDUDE; (2) as the Company’s retail partners began to destock this excess inventory, waning product demand further negatively impacted the Company’s financial results; and (3) as a result, defendants’ representations about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

WHAT’S NEXT? If you suffered a loss in Crocs during the relevant time frame, you have until March 24, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 – NMRA

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Neumora Therapeutics, Inc. (“Neumora Therapeutics, Inc.” or the “Company”) (NASDAQ: NMRA) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Neumora Therapeutics, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class of all persons or entities who purchased or otherwise acquired Neumora common stock pursuant and/or traceable to the Offering Documents, commenced on or about September 15, 2023. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=134638&wire=3

NMRA investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) in order for Neumora to justify conducting its Phase Three Program, Neumora was forced to amend BlackThorn’s original Phase Two trial inclusion criteria to include a patient population with moderate to severe Major Depressive Disorder, MDD, to show that Navacaprant, Neumora’s flagship therapeutic candidate, offered a statistically significant improvement in treating MDD; (2) and to that same end, the Company also added a prespecified analysis to the Phase Two statistical analysis plan, focusing on patients suffering from moderate to severe MDD; and (3) the Phase Two Trials lacked adequate data, particularly in regards to the patient population size and the ratio of male to female patients within the patient population, to be able to accurately predict the results of the KOASTAL-1 study.

WHAT’S NEXT? If you suffered a loss in Neumora Therapeutics, Inc. during the relevant time frame, you have until April 7, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 



Albertsons® Companies Announces New Goal to Enable 1.5 Billion Meals Across Local Communities by 2030

Albertsons® Companies Announces New Goal to Enable 1.5 Billion Meals Across Local Communities by 2030

Albertsons® Cos. Foundation’s Nourishing Neighbors program also pledges $10 million annually to help end the cycle of hunger

BOISE, Idaho–(BUSINESS WIRE)–
Albertsons® Companies, Inc. (NYSE: ACI) (“Albertsons”) and The Albertsons® Companies Foundation (“The Foundation”) announced two significant advancements in the company’s mission to help end the cycle of hunger during the South by Southwest® SXSW® Conference and Festivals. As part of the grocer’s Recipe for Change® impact framework, Albertsons will enable a new goal of 1.5 billion meals by 2030 through a combination of surplus food donations from stores and funds raised by the Foundation, after meeting its original goal of enabling more than one billion meals. Additionally, The Foundation’s Nourishing Neighbors program will invest $10 million annually to help break the cycle of hunger through various initiatives including its Innovation Spark Fund program; the E.A.T. curriculum for middle and high school students; a coalition created to tackle summer hunger; and other programs aimed at reducing food insecurity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250310006188/en/

Albertsons Companies and The Albertsons Companies Foundation announced significant advancements in the company’s mission to help end the cycle of hunger during the SXSW Conference and Festivals.
Image Courtesy: Albertsons Companies

Albertsons Companies and The Albertsons Companies Foundation announced significant advancements in the company’s mission to help end the cycle of hunger during the SXSW Conference and Festivals.
Image Courtesy: Albertsons Companies

“At Albertsons, we remain committed to fighting food insecurity in the communities we serve today while working to create lasting solutions to end hunger tomorrow, and forever,” said Jennifer Saenz, EVP of Pharmacy and E-Commerce for Albertsons and Board Chair for The Foundation. “The time for change is now as more than 44 million Americans, including 13.4 million children*, face the challenge of food insecurity, and we must come together across communities to solve this hunger crisis.”

Ending Hunger Today, Tomorrow, and Forever

In support of the Food Track at SXSW in Austin, Texas, Albertsons teamed up with Kellanova, maker of snacking brands like Pringles®, Cheez-It® and Pop-Tarts®, No Kid Hungry and Regen House, a collaboration between HowGood, EIT Food, and the Institute of Regeneration, to discuss viable solutions to tackle hunger. After unveiling Albertsons’ new meals goal and annual Foundation investment, Christy Duncan Anderson, President and Executive Director of The Foundation, participated in a lively panel discussion with Stephanie Slingerland, Chief Philanthropy Officer at Kellanova, and Anne Filipic, CEO at No Kid Hungry. During the panel, each participant discussed their organization’s approach to helping eradicate hunger as well as their programs and commitments to continue fighting food insecurity. Attendees were then invited to visit three stations at the event – Today, Tomorrow and Forever – to learn about actions they can take to help end the cycle of hunger.

“Food insecurity is a complex problem that requires collaboration to create long-term, lasting solutions,” said Duncan Anderson. “By partnering with Kellanova, No Kid Hungry and Regen House at such an innovative conference like SXSW, we have the unique opportunity to shine a light on hunger and the urgent need for communities to come together to address food insecurity and brainstorm innovative solutions.”

Nourishing Neighbors Program

Nourishing Neighbors, a charitable program of The Foundation, seeks to ensure at-risk children, adults, seniors and families have access to the food they need to thrive.

This past June, Nourishing Neighbors celebrated a decade of fighting hunger in local communities. Since the program’s inception in 2014, Nourishing Neighbors has raised more than $297 million for thousands of nonprofit organizations that are on the front lines of combatting hunger in America.

Donating Surplus Food to Local Communities

Each year, Albertsons stores donate millions of pounds of food to local food banks, pantries and other organizations that are on the front lines in the fight against hunger. As outlined in the latest Recipe for Change report, the company donated more than 92 million pounds of food from stores, distribution centers and manufacturing facilities in 2023, which is the equivalent of enabling over 76 million meals. Additionally, local stores support hunger relief efforts such as food drives and volunteer initiatives. Thanks to these efforts, combined with the generosity of Albertsons’ associates and customers, the company met our original goal of enabling more than one billion meals in 2023.

“A key component of our Recipe for Change framework is fighting food insecurity at a local level which is why we’re constantly exploring programs and partnerships that advance localized food donation solutions,” said Suzanne Long, Chief Sustainability and Transformation Officer for Albertsons. “We are incredibly proud of the progress we have made to date, and we’re keen to leverage and implement innovative practices as we work to achieve our new goal of enabling an additional 1.5 billion meals by 2030.”

For more information on The Foundation and Nourishing Neighbors, click here. For the 2024 Recipe for Change Report, click here.

To download related images, please click here.

*Household Food Security in the United States in 2022, page 10

About Albertsons® Companies, Inc.

Albertsons is a leading food and drug retailer in the United States. As of November 30, 2024, the Company operated 2,273 retail food and drug stores with 1,732 pharmacies, 405 associated fuel centers, 22 dedicated distribution centers and 19 manufacturing facilities. The Company operates stores across 34 states and the District of Columbia under more than 20 well known banners including Albertsons, Safeway, Vons, Jewel-Osco, Shaw’s, ACME, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen, Carrs, Kings Food Markets and Balducci’s Food Lovers Market. In 2023, along with the Albertsons Companies Foundation, the Company contributed more than $350 million in food and financial support, including more than $35 million through our Nourishing Neighbors Program to ensure those living in our communities and those impacted by disasters have enough to eat.

Media Relations: [email protected]

KEYWORDS: United States North America Idaho

INDUSTRY KEYWORDS: Other Philanthropy Supermarket Food/Beverage Philanthropy Online Retail Fund Raising Foundation Retail

MEDIA:

Photo
Photo
Albertsons Companies and The Albertsons Companies Foundation announced significant advancements in the company’s mission to help end the cycle of hunger during the SXSW Conference and Festivals.
Image Courtesy: Albertsons Companies
Logo
Logo

Shareholders of Newmont Corporation Should Contact Levi & Korsinsky Before April 1, 2025 to Discuss Your Rights – NEM

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Newmont Corporation (“Newmont” or the “Company”) (NYSE: NEM) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Newmont investors who were adversely affected by alleged securities fraud between February 22, 2024 and October 23, 2024. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=134636&wire=3

NEM investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the complaint, on October 23, 2024, Newmont published a press release announcing disappointing EBITDA third quarter 2024 highlights, in addition to decreases in production and increases in operating costs. In pertinent part, Newmont revealed that mining operations at its two Tier 1 assets would see lower production than originally guided with expectations of higher costs at these facilities. Following this news, Newmont’s stock price fell from a closing market price of $57.74 per share on October 23, 2024 to $49.25 per share on October 24, 2024.

WHAT’S NEXT? If you suffered a loss in Newmont during the relevant time frame, you have until April 1, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 28, 2025 in Quantum Computing Inc. Lawsuit – QUBT

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Quantum Computing Inc. (“Quantum Computing Inc.” or the “Company”) (NASDAQ: QUBT) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Quantum Computing Inc. investors who were adversely affected by alleged securities fraud between March 30, 2020 and January 15, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/quantum-computing-inc-lawsuit-submission-form?prid=134635&wire=3

QUBT investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) defendants overstated the capabilities of QCI’s quantum computing technologies, products, and/or services; (ii) defendants overstated the scope and nature of QCI’s relationship with NASA, as well as the scope and nature of QCI’s NASA-related contracts and/or subcontracts; (iii) defendants overstated QCI’s progress in developing a thin film lithium niobate, TFLN foundry, the scale of the purported TFLN foundry, and orders for the Company’s TFLN chips; (iv) QCI’s business dealings with Quad M and millionways both qualified as related party transactions; (v) accordingly, QCI’s revenues relied, at least in part, on undisclosed related party transactions; (vi) all the foregoing, once revealed, was likely to have a significant negative impact on QCI’s business and reputation; and (vii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in Quantum Computing Inc. during the relevant time frame, you have until April 28, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com